InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Abate Kristin, Directrice Comptable. Insider active across 1 company, notably Karyopharm Therapeutics Inc.. Aggregated, 13 disclosures have been published. Split: 0 buy · 8 sells. Total volume traded: €13k. History available since 28 February 2025. The latest transaction was filed on 14 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Abate Kristin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
53 股@ US$9.500.0011% mcap100.0% 占其流量Common StockSEC:0001193125-26-226616:1
121 股0Common StockSEC:0001193125-26-226616:0
559 股@ US$9.409535.4% 占其流量Common StockSEC:0002045943-26-000003:0
92 股0Common StockSEC:0001193125-26-029599:0
265 股@ US$5.9610.7% 占其流量Common StockSEC:0001193125-26-019428:0
12,799 股0Common StockSEC:0001193125-25-241487:0
362 股@ US$6.29628.5% 占其流量Common StockSEC:0001193125-25-230359:0
23 股@ US$6.433.2% 占其流量Common StockSEC:0001193125-25-205038:1
46 股0Common StockSEC:0001193125-25-205038:0
12 股@ US$6.781.4% 占其流量Common StockSEC:0002045943-25-000004:0
238 股@ US$4.0016.9% 占其流量Common StockSEC:0000950170-25-097965:0
571 股@ US$6.2986.0% 占其流量Common StockSEC:0000950170-25-034662:0
933 股0Common StockSEC:0000950170-25-032305:0
13 条申报中的 13 条
About Abate Kristin
Abate Kristin is Directrice Comptable and Chief Accounting Officer at Karyopharm Therapeutics Inc. She has 13 filings in total. In the sampled recent filings from 2025-03-04 to 2026-05-15, the activity consists only of sales, for a total of EUR 12626, with notable sales of EUR 4472.922065535538, EUR 3425.443139955753, and EUR 1942.337283102458.
